Global Antihistamine Drugs Market Trends, Business Overview, Industry Growth and Forecast to 2028

The global antihistamine drugs market is anticipated to grow at a significant CAGR of 8.7% during the forecast period 2022-2028. The major factor driving the growth of the market is the rising prevalence of allergic rhinitis and gastrointestinal conditions globally. According to NCBI, allergic rhinitis is a chronic upper airway inflammatory disease that affects around 60 million adults and children in the US alone. The increased research and development activities in order to develop new products for better treatment of these conditions is propelling the growth of the market. For instance, in June 2021, The US Food and Drug Administration (FDA) approved a nasal antihistamine for usage through a process called a partial prescription to nonprescription switch. The FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis in adults and children of six years and above. Seasonal and perennial allergies affect millions of people globally every year, causing them to experience symptoms of nasal congestion, runny nose, sneezing and more.

The market is segmented based on the drug type, application and end-user. Based on the drug type, the market is sub-segmented into H-1 receptor antagonists (including, brompheniramine, clemastine, diphenhydramine, loratadine, fexofenadine, and others), H-2 receptor antagonists (including, cimetidine, famotidine, nizatidine, and ranitidine), and others. Based on application, the market is sub-segmented into allergic rhinitis, insomnia, hay fever, heartburns, headaches, and others. Based on end-user, the market is sub-segmented into homecare, hospitals & clinics, and others. Among these end-users, the hospitals & clinics segment is anticipated to hold a prominent share in the market due to the increasing cases of allergic rhinitis and hay fever globally. The rise in the adoption of antihistamine drugs is the major cause of the growth of this segment.

Some major players in the market include Johnson & Johnson Services Ltd., Sanofi SA, Bayer AG, AstraZeneca PLC, GlaxoSmithKline PLC, Pfizer Inc., and Merck & Co. Inc. among others. The market players are helping significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay in the competition of the market. For instance, in March 2022, Miravo Healthcare had launched Blexten in Canada, for patients of 4 years and above for the treatment of the symptoms of seasonal allergic rhinitis and chronic spontaneous urticaria (such as itchiness and hives). The drug is available in 2.5mg/mL oral solution and (rapidly dispersing) 10mg orodispersible (quick melt) tablet formats.

Similarly, in March 2022, Allergan PLC announced that LASTACAFT (alcaftadine ophthalmic solution 0.25%) is now available without a prescription for the estimated 40% of Americans who live with ocular allergies. As demonstrated in clinical studies, one drop of LASTACAFT works in as little as three minutes to provide relief from itchy, allergy eyes lasting through 16 hours. Following the recent FDA approval of a complete prescription to over-the-counter (OTC) switch, the original patented prescription-strength formulation of LASTACAFT is now available online and in retail stores where OTC eye drops are sold. LASTACAFT is an antihistamine eye drop that temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair, and dander for ages two and older.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Drug Type
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Johnson & Johnson Services Ltd., Sanofi SA, Bayer AG, AstraZeneca PLC, GlaxoSmithKline PLC, Pfizer Inc., and Merck & Co. Inc. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Antihistamine Drugs Market Report by Segment

By Drug Type

• H-1 Receptor Antagonists
  • Brompheniramine
  • Clemastine
  • Diphenhydramine
  • Loratadine
  • Fexofenadine
  • Others
• H-2 Receptor Antagonists
  • Cimetidine
  • Famotidine
  • Nizatidine
  • Ranitidine
• Others

By Application

• Allergic Rhinitis
• Insomnia
• Hay Fever
• Heartburns
• Headaches
• Others

By End-User

• Homecare
• Hospitals and Clinics
• Others

Global Antihistamine Drugs Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa